hepatocellular carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Research subjects: RHCC patients who sought medical treatment at the First Affiliated Hospital of Sun Yat-sen University from June 2006 to December 2019; (2) Primary and recurrent tumors with pathological diagnosis of HCC; (3) Hepatectomy was performed for both primary and recurrent tumors; (4) The patient has not received liver resection treatment, local therapy, or molecular targeted therapy in the past; (5) Liver, blood and kidney function are all good; (6) The age range is between 18 and 75.
Exclusion criteria
Exclusion criteria: (1) Thrombosis or distant metastasis of vascular or biliary tract tumors; (2) Incomplete clinical data; (3) loss of follow-up; (4) Liver, blood and renal insufficiency; (5) Other malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alpha fetoprotein; | — |
Secondary
| Measure | Time frame |
|---|---|
| Age;Gender;Child Pugh class;Barcelona Clinic Liver Cancer staging;Etiology;Cirrhosis;Indocyanogen green 15-minute retention rate;Antiviral history;Tumor number and size;Portal vein thrombosis class;hepatitis B surface antigen(HbsAg);Hepatitis B virus-deoxyribonucleic acid;Diabetes;Neutrophil ratio;Lymphocyte ratio;Platelets(PLT);prothrombin time(PT);international normalized ratio(INR);Albumin ;serum total bilirubin(TBIL);alanine aminotransferase(ALT);aspartate aminotransferase(AST);gamma-glutamyltranspeptidase(?-GGT);Operation time;Blood loss;Blood transfusion;Operation method;Resection Margin;Tumor capsule;Complications;Tumor morphology;Microvascular invasion(MVI); | — |
Countries
China
Contacts
The First Affiliated Hospital of Sun Yat-Sen University